# King Edward Medical University

Organization · id `cardio:org-king-edward-medical-university` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 02rrbpf42](<https://ror.org/02rrbpf42>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 02rrbpf42 by an exact name.

## The registry's words

- Sponsor name: King Edward Medical University
- Sponsor class: OTHER
- ROR name: King Edward Medical University

## Connected pages

- Sponsors: Effect of Escalating Oral Vitamin D Replacement on HOMA-IR in Vitamin D Deficient Type 2 Diabetics (`cardio:ct-nct04183257`)
- Sponsors: Impact of Atorvastatin Versus Rosuvastatin on 25 Hydroxy Vitamin D Levels in Patients With Acute Coronary Syndrome (`cardio:ct-nct06765265`)
- Sponsors: Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention (`cardio:ct-nct07243080`)

## Provenance

Content hash: 6bc5c685fb86b5b24968279fdbbc4fa0e892dbd8ad99c10cd996d25d5b286054
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
